Care coordination is vital to ensure improved patient outcomes as both CMS and private payers are paying increased attention to it, pointed out Adam Brufsky, MD, PhD, co-director of the Comprehensive Breast Cancer Center at University of Pittsburgh. How is your institution infusing care coordination in its workflow?
Care coordination is vital to ensure improved patient outcomes as both CMS and private payers are paying increased attention to it, pointed out Adam Brufsky, MD, PhD, co-director of the Comprehensive Breast Cancer Center at University of Pittsburgh. How is your institution infusing care coordination in its workflow?
Transcript
Care coordination is somewhat of a buzz word and everyone defines it differently. In our institution, what we do is we have navigators that help the patients go between surgeons, medical oncologists, radiation therapists, physical therapists if they need them. In the early-stage disease, I think care coordination in the metastatic setting involves again I think radiation therapists and medical oncologists, and to some lesser extent, surgeons.
We have a common electronic medical record (EMR), we have patient navigators; I think the neat thing about EMR in general I think it’s really care everywhere. Meaning if a patient gets care at another institution that shares the same kind of medical record, in our case, Epic, we actually can go into that patient’s data on another institution which really helps enormously for care coordination. In the past, you would have to fax records to figure out what was going on. I think EMR is really helping a lot with care coordination.
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More